Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by zwerp2000on Dec 06, 2016 10:33am
134 Views
Post# 25559580

RE:RE:RE:Potential correction to $15+ tomorrow

RE:RE:RE:Potential correction to $15+ tomorrow i do follow the company and know a lot about it. i;ve been in since it was sctpf, pre reverse split levels at around $.22. do you know about the company? for you to predict $17/share after their presentation at ash was ridiculous. no one thought it would open at $17, come on. 
Bullboard Posts